NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 334 filers reported holding NATERA INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,598,080 | +30.6% | 116,337 | +10.3% | 0.09% | +56.4% |
| Q1 2024 | $9,643,934 | -31.3% | 105,444 | -52.9% | 0.06% | -39.6% |
| Q4 2023 | $14,032,965 | +297.3% | 224,026 | +180.7% | 0.09% | +250.0% |
| Q3 2023 | $3,531,770 | -31.6% | 79,814 | -24.8% | 0.03% | -23.5% |
| Q2 2023 | $5,166,278 | -24.3% | 106,171 | -13.6% | 0.03% | -19.0% |
| Q1 2023 | $6,821,866 | +112.9% | 122,872 | +54.0% | 0.04% | +121.1% |
| Q4 2022 | $3,204,281 | -58.4% | 79,768 | -54.6% | 0.02% | -55.8% |
| Q3 2022 | $7,706,000 | -1.6% | 175,864 | -20.4% | 0.04% | -10.4% |
| Q2 2022 | $7,828,000 | -48.4% | 220,867 | -40.8% | 0.05% | -62.5% |
| Q1 2022 | $15,178,000 | +125.3% | 373,105 | +417.3% | 0.13% | +100.0% |
| Q4 2021 | $6,736,000 | +46.4% | 72,131 | +74.7% | 0.06% | +10.3% |
| Q3 2021 | $4,601,000 | -46.3% | 41,286 | -45.3% | 0.06% | -40.2% |
| Q2 2021 | $8,566,000 | +165.9% | 75,454 | +137.8% | 0.10% | +136.6% |
| Q1 2021 | $3,222,000 | -67.8% | 31,736 | -68.4% | 0.04% | -70.1% |
| Q4 2020 | $9,995,000 | +99.8% | 100,435 | +45.0% | 0.14% | +85.1% |
| Q3 2020 | $5,002,000 | +68.2% | 69,244 | +16.1% | 0.07% | +45.1% |
| Q2 2020 | $2,974,000 | +16422.2% | 59,657 | +9842.8% | 0.05% | – |
| Q1 2020 | $18,000 | -99.5% | 600 | -99.4% | 0.00% | -100.0% |
| Q4 2019 | $3,494,000 | +149.7% | 103,709 | +143.2% | 0.06% | +128.6% |
| Q3 2019 | $1,399,000 | +39.5% | 42,643 | +17.2% | 0.03% | +55.6% |
| Q2 2019 | $1,003,000 | +93.3% | 36,381 | +44.6% | 0.02% | +5.9% |
| Q1 2019 | $519,000 | +134.8% | 25,160 | +58.9% | 0.02% | +70.0% |
| Q4 2018 | $221,000 | -33.4% | 15,832 | +14.2% | 0.01% | -44.4% |
| Q3 2018 | $332,000 | +31.7% | 13,868 | +3.7% | 0.02% | +38.5% |
| Q2 2018 | $252,000 | +514.6% | 13,376 | +280.8% | 0.01% | +333.3% |
| Q4 2016 | $41,000 | -24.1% | 3,513 | -27.4% | 0.00% | 0.0% |
| Q3 2016 | $54,000 | -23.9% | 4,840 | -17.2% | 0.00% | -25.0% |
| Q2 2016 | $71,000 | – | 5,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
| Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
| Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
| Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
| Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
| Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
| Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
| Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
| PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
| PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |